Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1186/bcr2929.pdf
Reference54 articles.
1. Hall JM, McDonnell DP: Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Mol Interv. 2005, 5: 343-357. 10.1124/mi.5.6.7.
2. Green KA, Carroll JS: Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat Rev Cancer. 2007, 7: 713-722. 10.1038/nrc2211.
3. Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999, 17: 1474-1481.
4. Hartman J, Strom A, Gustafsson JA: Estrogen receptor beta in breast cancer--diagnostic and therapeutic implications. Steroids. 2009, 74: 635-641. 10.1016/j.steroids.2009.02.005.
5. Moy B, Goss PE: Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approaches. Clin Cancer Res. 2006, 12: 4790-4793. 10.1158/1078-0432.CCR-06-1535.
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34;Breast Cancer Research and Treatment;2023-05-18
2. A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer;Cancer Research;2022-08-11
3. Therapeutic Efficacy of Roscovitine Against Cancer;Handbook of Oxidative Stress in Cancer: Therapeutic Aspects;2022
4. Altered Expression of ESR1, ESR2, PELP1 and c-SRC Genes Is Associated with Ovarian Cancer Manifestation;International Journal of Molecular Sciences;2021-06-09
5. FASN inhibition as a potential treatment for endocrine-resistant breast cancer;Breast Cancer Research and Treatment;2021-04-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3